AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2002 MAY 15 - (NewsRx.com & NewsRx.net) -- Nabi (NABI) announced that it has changed its name to Nabi Biopharmaceuticals. This change recognizes the completion of the company's strategic transition to become a vertically integrated biopharmaceutical company.
The company's focus is on the development and commercialization of novel vaccines and antibody based therapies to treat and prevent infectious, autoimmune, and addictive diseases.
"In 2001, we completed the sale of the majority of our antibody business, which provided us with both the financial resources and ability to focus fully on the advancement of our innovative product pipeline," said David J. Gury, chairman, president, and chief executive officer. "We also received FDA ...